Where does Nyxoah SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nyxoah SA ranks #7,056 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nyxoah SA hold?

Nyxoah SA holds 47 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Nyxoah SA's Innovation Score?

Nyxoah SA has an Innovation Score of 34.4 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nyxoah SA focus on?

Nyxoah SA's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 42 patents, ranking #88 of 1,943 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Nyxoah SA's patent grant rate increasing or decreasing?

Nyxoah SA's recent grant velocity is -36% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Nyxoah SA's patents?

Nyxoah SA's patents average 11.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nyxoah SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nyxoah SA

USPTO PatentsView assignee record - 47 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nyxoah ranks #7,056 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 7 technology areas.

#7,056
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.4/100): 11.7
avg claims per patent: -36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7056 · Foreign Corporation #7,056 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,056/49,997
PHOTO-FINISH Nankai University
CPC-NARROW A61N · 7 areas
INNOV-THIN 34.4/100
CLAIMS-PAR 11.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nankai University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nyxoah’s 34.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (39%) Velocity 4.6 pts (13%) Breadth 9.4 pts (27%) Claim depth 7.0 pts (20%)

Qualcomm Incorporated · highest

85
Karl Storz Endovision · near

34
Nyxoah · this assignee

34
Royal Group · near

34
Tricam Industries · near

34
Vaxiion Therapeutics · near

34
3D Lighting… · lowest

7

What this shows Nyxoah's Innovation Score is 34.4/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nyxoah?

Each dot is one of Nyxoah’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nyxoah’s own 11.7 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Nyxoah vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nyxoah's grants concentrate

Nyxoah SA is a focused PatentsView assignee: 7 CPC subclasses with 89.4% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (10 grants) versus a trough of 1 in 2024. By volume, Nyxoah sits between Nuovo Pignone SPA and Pharnext.

Nyxoah's three-year grant acceleration

Nyxoah SA shows 9 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nuovo Pignone SPA

47
Nankai University

47
National Institut…

47
Nextiva

47
Ospedale SAN Raff…

47
Optinose AS

47
Pfeiffer Vacuum

47
Pharnext

47
Nyxoah ◀

47

What this shows Nyxoah holds 47 patents at rank #7,055, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nyxoah

By rank, the assignees closest to #7,055 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Nyxoah's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nyxoah, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Nyxoah ranks #88 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Royal Group, Inc. 34 Tricam Industries, LLC 34 Karl Storz Endovision, Inc. 34 Vaxiion Therapeutics, LLC 34

Nyxoah's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Nyxoah SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	12.8%
2016	10	21.3%
2017	2	4.3%
2018	6	12.8%
2019	4	8.5%
2020	5	10.6%
2021	4	8.5%
2022	4	8.5%
2023	4	8.5%
2024	1	2.1%
2025partial year	1	2.1%

Which technologies does Nyxoah SA patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 42

A61B - DIAGNOSIS; SURGERY; Identification 36

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 21

H04B - Transmission 18

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 12

Y10T - Technical Subjects Covered BY Former US Classification 11

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 3

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nyxoah SA's patent record in context - here's where to go next.

Nyxoah SA's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 89.4% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,056 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nyxoah SA against Nuovo Pignone SPA, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.